Bone Biologics (BBLG) Interest & Investment Income (2014 - 2025)
Bone Biologics (BBLG) reported Interest & Investment Income of $47964.0 for Q4 2025, up 136.7% year-over-year from $20264.0 in Q4 2024, and up 1.35% quarter-over-quarter from $47325.0 in Q3 2025.
Bone Biologics (BBLG) Interest & Investment Income (2014 - 2025) Analysis & Trends
Bone Biologics (BBLG) has 4 years of Interest & Investment Income data on file, last reported at $47964.0 in Q4 2025.
- Interest & Investment Income for Q4 2025 came in at $47964.0, up 136.7% year-over-year; the trailing twelve-month figure through Dec 2025 was $121982.0 (up 119.16% YoY), and the FY2025 annual result was $121984.0, up 119.16% from the prior year.
- Interest & Investment Income climbed to $47964.0 in Q4 2025 per BBLG's latest filing, from $47325.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $47964.0 in Q4 2025 and troughed at $255.0 in Q1 2024.
- A 3-year average of $16268.5 and a median of $15147.0 in 2024 frame the typical range for Interest & Investment Income.
- On a YoY basis, Interest & Investment Income climbed as much as 7758.43% in 2025 and fell as far as 56.07% in 2025.
- A 3-year view of Interest & Investment Income shows it stood at $349.0 in 2023, then jumped by 5706.3% to $20264.0 in 2024, then surged by 136.7% to $47964.0 in 2025.
- Business Quant data shows BBLG's Interest & Investment Income at $47964.0 in Q4 2025, $47325.0 in Q3 2025, and $6654.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -14.79 Mn |
| 10 | Bone Biologics | 1.45 Mn | 1.45 Mn | - | 47,964.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 47,964.00 |
| Sep 30, 2025 | 47,325.00 |
| Jun 30, 2025 | 6,654.00 |
| Mar 31, 2025 | 20,039.00 |
| Dec 31, 2024 | 20,264.00 |
| Sep 30, 2024 | 19,993.00 |
| Jun 30, 2024 | 15,147.00 |
| Mar 31, 2024 | 255.00 |
| Dec 31, 2023 | 349.00 |
| Sep 30, 2023 | 536.00 |
| Jun 30, 2023 | 428.00 |
| Sep 30, 2014 | -877,704.00 |